Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients and catalyst technologies, has received GMP approval for its facilities in Annan, UK, following a program of renovation and refitment. The company has made investments to refurbish the site, which is now fully equipped for GMP manufacturing. The certification follows a successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA), with no critical or major observations. The site is now ready to commence production.

Johnson Matthey Fine Chemicals is recruiting for 35 new vacancies at the Annan site across a variety of manufacturing and operational positions. Johnson Matthey acquired the Annan facility in November 2014 to expand the fine chemicals division’s large-volume capacity.

Source: Johnson Matthey